Misdiagnosis Worsens Prognosis in Subarachnoid Hemorrhage With Good Hunt and Hess Score

  • Angel Ois
    From the Department of Neurology, Hospital del Mar, Barcelona, Spain (A.O., G.F.-A., E.C.-G., C.A., B.B.-R., A.R.-C., J.R.)
  • Elio Vivas
    J.J. Merland Department of Therapeutic Neuroangiography of Hospital del Mar and Hospital Universitari General de Catalunya, Spain (E.V., L.G., J.S.)
  • Georgina Figueras-Aguirre
    From the Department of Neurology, Hospital del Mar, Barcelona, Spain (A.O., G.F.-A., E.C.-G., C.A., B.B.-R., A.R.-C., J.R.)
  • Leopoldo Guimaraens
    J.J. Merland Department of Therapeutic Neuroangiography of Hospital del Mar and Hospital Universitari General de Catalunya, Spain (E.V., L.G., J.S.)
  • Elisa Cuadrado-Godia
    From the Department of Neurology, Hospital del Mar, Barcelona, Spain (A.O., G.F.-A., E.C.-G., C.A., B.B.-R., A.R.-C., J.R.)
  • Carla Avellaneda
    From the Department of Neurology, Hospital del Mar, Barcelona, Spain (A.O., G.F.-A., E.C.-G., C.A., B.B.-R., A.R.-C., J.R.)
  • Bernat Bertran-Recasens
    From the Department of Neurology, Hospital del Mar, Barcelona, Spain (A.O., G.F.-A., E.C.-G., C.A., B.B.-R., A.R.-C., J.R.)
  • Ana Rodríguez-Campello
    From the Department of Neurology, Hospital del Mar, Barcelona, Spain (A.O., G.F.-A., E.C.-G., C.A., B.B.-R., A.R.-C., J.R.)
  • Maria-Pilar Gracia
    Department of Intensive Care (M.-P.G.), Hospital del Mar, Barcelona, Spain.
  • Gloria Villalba
    Department of Neurosurgery (G.V.), Hospital del Mar, Barcelona, Spain.
  • Jesus Saldaña
    J.J. Merland Department of Therapeutic Neuroangiography of Hospital del Mar and Hospital Universitari General de Catalunya, Spain (E.V., L.G., J.S.)
  • Jaume Capellades
    Department of Radiology (J.C.), Hospital del Mar, Barcelona, Spain.
  • Juan-Luis Fernández-Candil
    Department of Anesthesia (J.L.F.-C.), Hospital del Mar, Barcelona, Spain.
  • Jaume Roquer
    From the Department of Neurology, Hospital del Mar, Barcelona, Spain (A.O., G.F.-A., E.C.-G., C.A., B.B.-R., A.R.-C., J.R.)

抄録

<jats:sec> <jats:title>Background and Purpose—</jats:title> <jats:p>Our aim was to describe variables associated with initial misdiagnosis of subarachnoid hemorrhage (SAH). We also analyzed the relationship of misdiagnosis with poor outcome and complications in good Hunt and Hess (HH) cases.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods—</jats:title> <jats:p>In a prospective cohort of 401 patients with SAH, misdiagnosis was defined as failure to correctly identify, at first physician contact, a subsequently documented SAH; this meant no urgent radiological study and lumbar puncture was performed. Poor outcome was defined as modified Rankin Scale score 3 to 6 at 3-month follow-up. We recorded age, sex, hypertension, diabetes mellitus, current smoking, previous antithrombotic treatment, initial HH and radiological severity, presence of aneurysm, first therapeutic procedure, hydrocephalus, delayed cerebral ischemia (DCI), rebleeding, and procedure-related complications.</jats:p> </jats:sec> <jats:sec> <jats:title>Results—</jats:title> <jats:p>Misdiagnosis was confirmed in 104/401 (25.9%) patients, who also had a longer time-to-admission to hospital. Misdiagnosis was associated with less clinical and radiological severity, compared with a correct diagnosis; the 2 groups did not differ in age or cardiovascular risk factor profile. Poor outcome was registered in 167/401 patients (41.6%). Age, misdiagnosis, and greater clinical and radiological initial severity were independent predictors of poor outcome. In the 236 patients (58.8% of cohort) with HH 1–2, misdiagnosis was associated with poor outcome in univariate and multivariate analysis, respectively (odds ratio=3.89; 95% CI, 1.89–8.01). Delayed cerebral ischemia (odds ratio=2.47; 95% CI, 1.2–5.09) and procedure-related complications (odds ratio=2.27; 95% CI, 1.07–4.82) were independently associated with misdiagnosis.</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions—</jats:title> <jats:p>Misdiagnosis is an unresolved problem in SAH, and it is a missed opportunity for good outcome in patients with HH 1–2. The poor outcome is partially explained by a higher risk of delayed cerebral ischemia and procedure-related complications in misdiagnosed patients. There is a need to improve the diagnostic strategy in patients reporting only a headache (HH 1–2) after SAH.</jats:p> </jats:sec>

収録刊行物

  • Stroke

    Stroke 50 (11), 3072-3076, 2019-11

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ